Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
4(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
3
15%
Ph phase_3
3
15%
Ph phase_4
5
25%
Ph early_phase_1
1
5%
Ph not_applicable
4
20%

Phase Distribution

1

Early Stage

3

Mid Stage

8

Late Stage

Phase Distribution16 total trials
Early Phase 1First-in-human
1(6.3%)
Phase 2Efficacy & side effects
3(18.8%)
Phase 3Large-scale testing
3(18.8%)
Phase 4Post-market surveillance
5(31.3%)
N/ANon-phased studies
4(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

4

trials recruiting

Total Trials

20

all time

Status Distribution
Active(4)
Completed(9)
Terminated(1)
Other(6)

Detailed Status

Completed9
unknown6
Recruiting4
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
20
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (6.3%)
Phase 23 (18.8%)
Phase 33 (18.8%)
Phase 45 (31.3%)
N/A4 (25.0%)

Trials by Status

unknown630%
completed945%
recruiting420%
withdrawn15%

Recent Activity

Clinical Trials (20)

Showing 20 of 20 trials
NCT07499804Phase 4

Effect of Tadalafil on Endometrial Thickness and Frozen Embryo Transfer Outcomes

Recruiting
NCT07447518Early Phase 1

Double j Stent Related Symptoms

Completed
NCT06543628Not Applicable

Evaluation of Tadalafil Combined With LIPUS for Treating Erectile Dysfunction

Completed
NCT06809205Phase 4

Efficacy and Safety of Tadalafil, Tamsulosin, and Their Combinations in Treating Lower Urinary Tract Symptoms in BPH Patients with Prostate Volumes ≤ 40 Ml: a Prospective Comparative Study

Completed
NCT06788704

Tadalafil Daily Used Post Turp

Completed
NCT06583590Phase 2

Evaluation of Efficacy of Botulinum Toxin A Plus Oral Tadalafil 5 mg in Diabetic Men With Erectile Dysfunction

Recruiting
NCT05458232

Use of a Phosphodiesterase Type 5 Inhibitor to Improve Anabolic Resistance in Older Adults

Withdrawn
NCT05558007Phase 2

Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients

Recruiting
NCT06520839Phase 3

Genetic Factors of Erectile Dysfunction Degree and Response to Tadalafil Treatment in Patients With Diabetes

Recruiting
NCT06184334Not Applicable

Management of OAB in Female Patients .

Completed
NCT05537272Phase 4

The Efficacy of Tamsulosin and Tadalafil Compared to Placebo in the Treatment and Prevention of Urinary Disorders After Transperineal Prostate Biopsy

Unknown
NCT05494567Phase 4

Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OAB

Unknown
NCT05446493Phase 4

Serum YKL-40 Level and Platelets Indices Among Patients With Diabetic Erectile Dysfunction

Completed
NCT05266651Phase 2

Efficiency of Tadalafil for Management of Female Sexual Dysfunction

Unknown
NCT05146674Not Applicable

Impact of Tadalafil 5 mg on Post-micturition Dribble in Young-age Men With no/Mild Lower Urinary Tract Symptoms

Unknown
NCT04577040

Safety and Efficacy of Tadalafil vs. Tadalafil With Sildosin in the Management of Moderately and Severely Symptomatic Patients of Prostatic Hyperplasia

Unknown
NCT04446598Not Applicable

Management of Prostatodynia in Younger Patients With Non-ablative Erbium:YAG Intraurethral Laser

Completed
NCT04383093

Tadalafil Plus Tamsulosin for Male LUTS and ED

Completed
NCT03246880Phase 3

Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients

Completed
NCT02862483Phase 3

The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile Dysfunction

Unknown

All 20 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
20